‘Search and destroy’ treatment improves quality of life for patients with advanced prostate cancer 08 Sep 2023 A new radioactive medicine that seeks out tumour cells to deliver a targeted dose of radiation greatly improves quality of life for patients with advanced prostate cancer, a phase III study finds. Find out more Show/Hide
ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein 03 Jun 2022 A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer. Find out more Show/Hide
ESMO 2021: Drug combination shows promise in treatment-resistant advanced ovarian cancer 19 Sep 2021 A new combination of targeted drugs for a type of ovarian cancer has shown promising results in an early clinical trial – shrinking tumours in half of patients. Find out more Show/Hide
AACR Annual Meeting 2021: Immunotherapy combination shows early promise in aggressive brain cancers 11 Apr 2021
AACR Virtual Annual Meeting 2020: Personalised cancer vaccine shows promise in early trial 22 Jun 2020